ChemicalsMid capRs 17,274 crRs 15.5 cr traded a day
Close on 2026-08-21
431.15
−0.65%
52-week range12% of the way up
412.25569.75
Market cap
17,274 cr
P/E (TTM)
9.0×
industry 36×
EPS (TTM)
48.12
Revenue YoY
-11.8%
Q1 FY27
Profit YoY
-4.6%
Net margin
10.4%
+0.8pt vs a year ago
Growth trend
-25.5pt
vs last quarter’s YoY
1 month
-0.2%
Below 52w high
32.1%
RSI (14)
19
oversold
Daily swing
1.6%
average true range
Volume
1.1×
vs 20-day average
Traded
Rs 16 cr
median day
Close200-day averageMaterial filing
260 sessions · hover for the filing behind a move
1 week
−2.61%
1 month
−0.16%
3 months
−9.79%
6 months
−6.03%
1 year
−22.88%
The read
written from the numbers on this page
The evidence leans negative2 supporting, 4 against, 1 worth knowing
Supporting
matches near a 52-week low, which has beaten the market by +0.45 points over 20 sessions across 47,393 past signals
priced at 9× earnings against an industry median of 36× — 75% below its peers
Against
trading 4% below its 200-day average
at 12% of its 52-week range — nearly everyone who bought in the past year is underwater
down 23% over twelve months
revenue fell 12% year on year in the quarter ending 2026-06-30
Worth knowing
RSI at 19 is washed out — historically the better half of this site's measured edge comes from exactly this condition
What would change this read: a close back above 450, its 200-day average.
Assembled automatically from the figures on this page — the scans matched, their measured record, the filed financials, the derivatives positioning and the peer comparison. It is not a recommendation, no one has spoken to the company, and every claim above can be checked against a number further down this page.
What is working, what is not
read from the filings, with the figure behind every line
Working
Nothing in the filings stands out either way.
Needs watching1
Revenue -11.8% year on year, Rs 5,698 cr to Rs 5,027 cr.
-11.8%Rs 5,698 crRs 5,027 cr
Every figure here is computed from the company’s own filings. The wording is generated directly from the figures.
How it has performed
price return over each window, measured against zero
What the scans say today
1 of 47 matched on 2026-08-21
CHAMBLFERT matches 1 of the 47 scans today, across 1 different kinds of evidence.
CHAMBLFERT trades at 9× trailing earnings, below its median of 12× over this window — 26% less expensive than usual. The band runs from the 5th to the 95th percentile, so single-day spikes do not set the edges.
This window is short by the standards of valuation history — it begins where four quarters of filed earnings first exist. A stock can look cheap against two years and expensive against ten.
M&A filings were typically +0.23pt vs the market over the next 5 sessions (n=981) · Other filing filings were typically -0.08pt vs the market over the next 5 sessions (n=12,093)
The business
from the company’s filed results
Everything below is taken from the company’s own quarterly filing with the exchange — the XBRL document it submitted, not a vendor’s summary of it. Figures in rupees crore.
RevenueNet profit, drawn inside its revenue barNet margin, own scale belowrupees crore, per quarter as filed. Revenue bars start at zero.
Going for it
net margin widened from 6.1% to 10.4%
Going against it
revenue fell 12% against the same quarter a year earlier
profit dropped 5% year on year
Quarter-by-quarter numbers, as filed
Quarter
Revenue
Profit before tax
Net profit
EPS
Net margin
Q1 FY27
2026-06-30 · consolidated
5,027
772
524
13.07
10.4%
Q4 FY26
2026-03-31 · consolidated
2,785
191
169
4.23
6.1%
Q3 FY26
2025-12-31 · consolidated
5,898
746
586
14.64
9.9%
Q2 FY26
2025-09-30 · consolidated
6,413
795
649
16.19
10.1%
Q1 FY26
2025-06-30 · consolidated
5,698
717
549
13.70
9.6%
Q4 FY25
2025-03-31 · consolidated
2,449
137
130
3.25
5.3%
Quarterly filings are unaudited unless stated. Consolidated figures are used where the company files both. A single quarter is a noisy thing — the trend across the column is worth more than the top row.
Where the price stands
the same figures every scan on this site is computed from
Trend
Distance from the averages traders watch. Above all of them is a bull phase; below the 200-day is the line most investors use to say otherwise.
Versus 50-day average-5.5%
Versus 200-day average-4.2%
Below 52-week high-24.3%
Above 52-week low+4.6%
Momentum
How hard it has been pushed lately. Above 70 on RSI is stretched, below 30 is washed out — neither is a signal on its own.
RSI (14)19.2
Higher closes in last 51 of 5
Six-month return−6.03%
Risk and liquidity
What a position costs to hold and to exit. Position sizing starts with the daily swing, not with conviction.
Typical daily swing (ATR)1.65%
Volume versus 20-day1.1x
Median daily turnoverRs 15.5 cr
Peers
Chemicals · 44 classified companies
CHAMBLFERT trades at 9.0× trailing earnings against an industry median of 36.0× across 41 other classified companies in its industry — cheaper than them, by 75%. A multiple is a statement about expectations, not about quality: cheap usually means the market expects less, and it is often right.
largest twelve by market capitalisation. Market cap and P/E need filed financials, so blanks are companies whose filings have not been read yet
Recent sessions
what this stock has matched since the engine went live
This is the live record, not the backtest — the scans this stock actually appeared in on each stored session. A name that keeps reappearing is in a persistent condition; a one-day appearance usually is not.